An open-label phase I trial of a live attenuated H2N2 influenza virus vaccine in healthy adults.
about
H5N1 vaccines in humansA Single Dose of an Avian H3N8 Influenza Virus Vaccine Is Highly Immunogenic and Efficacious against a Recently Emerged Seal Influenza Virus in Mice and FerretsReplication of live attenuated cold-adapted H2N2 influenza virus vaccine candidates in non human primates.Development of live attenuated influenza vaccines against pandemic influenza strains.Evaluation of three live attenuated H2 pandemic influenza vaccine candidates in mice and ferrets.A live attenuated influenza A(H5N1) vaccine induces long-term immunity in the absence of a primary antibody response.Development and pre-clinical evaluation of two LAIV strains against potentially pandemic H2N2 influenza virus.The matrix gene segment destabilizes the acid and thermal stability of the hemagglutinin of pandemic live attenuated influenza virus vaccinesH2N2 live attenuated influenza vaccine is safe and immunogenic for healthy adult volunteers.Safety, immunogenicity and infectivity of new live attenuated influenza vaccines.Evaluation of the Safety and Immunogenicity of a Candidate Pandemic Live Attenuated Influenza Vaccine (pLAIV) Against Influenza A(H7N9).Evaluation of multivalent H2 influenza pandemic vaccines in mice.Animal models for influenza viruses: implications for universal vaccine developmentRandomized comparative study of the serum antihemagglutinin and antineuraminidase antibody responses to six licensed trivalent influenza vaccines.Experimental infection of adults with recombinant wild-type human metapneumovirus.Construction of eukaryotic expression vector with mBD1-mBD3 fusion genes and exploring its activity against influenza A virus.Prospects for oral replicating adenovirus-vectored vaccines.Intranasal live influenza vaccine priming elicits localized B cell responses in mediastinal lymph nodes.
P2860
Q27000896-E7D04BE3-4821-4CFD-9E25-5B4F92EFC6A6Q30204020-FFDE695E-B10A-4EA4-BDDC-53E7EB7A1EF8Q30206089-97594F7C-9F93-4F81-9992-2DF2EF7D07A0Q30209998-0C119E8D-9B2E-40F0-ABD0-7375F770CC71Q30357270-9809569E-3B60-42C2-8424-7B1262F1C5CEQ30359896-6BBA8622-FA10-4666-830E-390646409A59Q30365079-423087A9-EDB9-484B-A675-5D128E43C24DQ30365696-9ADE9557-DF45-4DC3-AE71-7BAAA335A449Q30373298-9E2F60DE-61D0-4695-8359-FCEC840384FFQ30378132-0830E3E2-2B1A-4BA4-989E-2F714619848AQ30382351-80144FE2-8566-49E2-945A-FB473E93645FQ30398507-971592C6-E806-4CE3-ABF9-368085621F5DQ34809686-BBA39CD2-3B89-4B9F-BBD3-58ABDCC621F2Q36462309-F18F8178-6853-4DC9-A894-4CA96C268B50Q37247449-A2300CD0-7370-4885-A2AA-333ED8C83173Q37673134-45F7BFE5-516D-4420-ADE2-54AA9ED10598Q38109356-89AD5EEE-4926-49EA-AF4B-8B67E2F61403Q50146914-BD6B14F2-4762-4D93-AAE4-524F9261A2CC
P2860
An open-label phase I trial of a live attenuated H2N2 influenza virus vaccine in healthy adults.
description
2012 nî lūn-bûn
@nan
2012 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի մարտին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
An open-label phase I trial of ...... rus vaccine in healthy adults.
@ast
An open-label phase I trial of ...... rus vaccine in healthy adults.
@en
type
label
An open-label phase I trial of ...... rus vaccine in healthy adults.
@ast
An open-label phase I trial of ...... rus vaccine in healthy adults.
@en
prefLabel
An open-label phase I trial of ...... rus vaccine in healthy adults.
@ast
An open-label phase I trial of ...... rus vaccine in healthy adults.
@en
P2093
P2860
P50
P1476
An open-label phase I trial of ...... rus vaccine in healthy adults.
@en
P2093
Bhagvanji Thumar
Bridget A McMahon
Catherine J Luke
Elaine W Lamirande
George W Kemble
Grace L Chen
Ji-Young Min
Kathy L Coelingh
Kawsar R Talaat
Philana H Liang
P2860
P356
10.1111/J.1750-2659.2012.00350.X
P577
2012-03-14T00:00:00Z